Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001213900-20-029412

CEO and CFO bought 16,667 shares at $4.60 ($76,710)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-29 Purchase : show line 1 in the form +16,667 $4.60 $76,710 1,184,839 D
Open-market purchases · 16,667 sh · avg $4.60 · $76,710
Loading xslF345X03/ownership.xml…